Has Brittany Kay received payments from drug or device companies?

Yes. Drug and device makers reported $9,353 in general payments to Brittany Kay across 135 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brittany Kay did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brittany Kay come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brittany Kay

Optometrist · Hubbard, OHNPI 1225679210

Payments from drug & device makers

$9,353in general payments, 2019–2025

Across 135 payments — averaging $69.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alcon$3K
Bausch & Lomb Americas Inc.$2K
Biotissue Holdings Inc.$2K
AbbVie$589
Sun Pharmaceutical Industries Inc.$494
Oyster Point Pharma, Inc.$357
plus $1K from 12 others

What the payments were for

Travel & lodging$3,28435%
Food & beverage$6,06965%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alcon	28	$2,884
Bausch & Lomb Americas Inc.	18	$2,301
Biotissue Holdings Inc.	22	$1,569
AbbVie(2 entities)	14	$589
Sun Pharmaceutical Industries Inc.	17	$494
Oyster Point Pharma, Inc.	8	$357
Kala Pharmaceuticals, Inc.	5	$271
Coopervision Inc.	6	$270
Tarsus Pharmaceuticals, Inc.	2	$182
Dompe US, Inc.	2	$107
Lombart Brothers, Inc.	2	$61
ABB Con-cise Optical Group LLC	2	$59
Sight Sciences, Inc.	1	$54
Novartis	2	$43
Bausch & Lomb, A Division Of Bausch Health US, LLC	2	$36
Johnson & Johnson Vision Care, Inc.	2	$34
Astellas Pharma US Inc	1	$22
Carl Zeiss Meditec USA, Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,353 in reported general payments places this provider in the 95th percentile of 1,995 optometrist providers in Ohio.

See all optometrist providers in Ohio →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
RestasisCyclosporine	17	$21,177
LumiganBimatoprost	15	$11,380
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol	15	$2,662
Latanoprost	241	$1,486
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	70	$1,065
Doxycycline Monohydrate	26	$946
Brimonidine Tartrate	33	$176
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	18	$169
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha	24	$168
Timolol Maleate	38	$159
Dorzolamide Hcl	17	$143
Methylprednisolone	15	$71

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieRestasis, Lumigan	$589	$32,55732 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,995 optometrist providers in Ohio.

Other optometrist in Hubbard

Katherine BickleGranville$3M
Jennifer FogtColumbus$1.9M
Jason MillerPowell$1.4M
Mile BrujicBowling Green$1.3M
William LayWesterville$891K
Gregory DenaeyerColumbus$846K
Thomas ChesterCleveland$786K
Loretta Szczotka-FlynnCleveland$388K
Cory LappinMontgomery$367K
Dustin GardnerMarysville$314K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →